Facebook Facebook icon Twitter Twitter icon LinkedIn LinkedIn icon Email



Riad Sherif

25 November 2021 in Podcasts

Oculis CEO Riad Sherif talks about the importance of expert investors, community engagment and setting the agenda in the Biotech industry After reaching the top of the pharmaceutical industry, his urge to join...

Apple Google Spotify

Riad Sherif is a true expert in his field. Trained as a doctor, his drive to succeed in business led him to pharmaceuticals and a successful 25-year career at corporate giants like Sanofi and Novartis.

In 2017, he joined the Swiss startup Oculis and as CEO he’s steered the biotech company to financial and regulatory success.

Oculis is developing a non-invasive treatment for diabetes-induced blindness which, if successful, could improve access to care for millions. In May, the company secured a $57 million financing round enabling it to expand its groundbreaking medical research.

In conversation with IMD President Jean-Francois Manzoni, Riad Sherif talks about the importance of expert investors, how engaging with the community can build your professional network, and why you should never take a meeting without an agenda.


Host: IMD President Jean-François Manzoni 

Guest: Riad Sherif

Produced by JohnJo Devlin

Listen to our new series

Learn Brain Circuits

Join us for daily exercises focusing on issues from team building to developing an actionable sustainability plan to personal development. Go on - they only take five minutes.
Read more 

Explore Leadership

What makes a great leader? Do you need charisma? How do you inspire your team? Our experts offer actionable insights through first-person narratives, behind-the-scenes interviews and The Help Desk.
Read more

Join Membership

Log in here to join in the conversation with the I by IMD community. Your subscription grants you access to the quarterly magazine plus daily articles, videos, podcasts and learning exercises.
Sign up

Log in or register to enjoy the full experience

Explore first person business intelligence from top minds curated for a global executive audience